Cardio Diagnostics Holdings, Inc. Cash Flow Statement
CDIO|4 years of annual SEC 10-K data (FY2022-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
Cardio Diagnostics Holdings, Inc. used $5M in operating cash flow and negative free cash flow of $5M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income | -$8.4M | -$8.4M | -$4.7M | -$620.4K |
| Depreciation & Amortization | $19.7K | $19.2K | $16.0K | $16.0K |
| Operating Cash Flow | -$5.0M | -$5.7M | -$5.1M | -$585.3K |
| Capital Expenditures | $214.8K | $575.7K | $575.7K | - |
| Free Cash Flow | -$5.2M | -$6.2M | -$5.7M | - |
| FCF Margin | -14926.5% | -36612.0% | -596487.5% | - |